Literature DB >> 22481411

Getting to the core of addiction: Hooking CB2 receptor into drug abuse?

Marisela Morales1, Antonello Bonci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22481411      PMCID： PMC9479678          DOI： 10.1038/nm.2722

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  13 in total

Review 1.  The cannabinoid system and immune modulation.

Authors:  Thomas W Klein; Cathy Newton; Kellie Larsen; Lily Lu; Izabella Perkins; Liang Nong; Herman Friedman
Journal:  J Leukoc Biol       Date:  2003-07-01       Impact factor: 4.962

Review 2.  The endocannabinoid system and its therapeutic exploitation.

Authors:  Vincenzo Di Marzo; Maurizio Bifulco; Luciano De Petrocellis
Journal:  Nat Rev Drug Discov       Date:  2004-09       Impact factor: 84.694

Review 3.  The role of microglia in the healthy brain.

Authors:  Marie-Ève Tremblay; Beth Stevens; Amanda Sierra; Hiroaki Wake; Alain Bessis; Axel Nimmerjahn
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 4.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 6.  Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.

Authors:  Nephi Stella
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

7.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

Authors:  L A Matsuda; S J Lolait; M J Brownstein; A C Young; T I Bonner
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

8.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

9.  Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.

Authors:  Jian-Ping Gong; Emmanuel S Onaivi; Hiroki Ishiguro; Qing-Rong Liu; Patricia A Tagliaferro; Alicia Brusco; George R Uhl
Journal:  Brain Res       Date:  2006-02-09       Impact factor: 3.252

10.  Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice.

Authors:  Zheng-Xiong Xi; Xiao-Qing Peng; Xia Li; Rui Song; Hai-Ying Zhang; Qing-Rong Liu; Hong-Ju Yang; Guo-Hua Bi; Jie Li; Eliot L Gardner
Journal:  Nat Neurosci       Date:  2011-07-24       Impact factor: 24.884
View more
  15 in total

1.  G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

2.  URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors.

Authors:  Angel Escamilla-Ramírez; Esperanza García; Guadalupe Palencia-Hernández; Ana Laura Colín-González; Sonia Galván-Arzate; Isaac Túnez; Julio Sotelo; Abel Santamaría
Journal:  Neurotox Res       Date:  2017-01-14       Impact factor: 3.911

3.  Multilayer photodynamic therapy for highly effective and safe cancer treatment.

Authors:  Ling Yang; Shaojuan Zhang; Xiaoxi Ling; Pin Shao; Ningyang Jia; Mingfeng Bai
Journal:  Acta Biomater       Date:  2017-03-09       Impact factor: 8.947

4.  Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors.

Authors:  Marisol Maya-López; Ana Laura Colín-González; Gabriela Aguilera; María Eduarda de Lima; Ana Colpo-Ceolin; Edgar Rangel-López; Juana Villeda-Hernández; Daniel Rembao-Bojórquez; Isaac Túnez; Armando Luna-López; Roberto Lazzarini-Lechuga; Viridiana Yazmín González-Puertos; Pedro Posadas-Rodríguez; Alejandro Silva-Palacios; Mina Königsberg; Abel Santamaría
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.

Authors:  Isabella Canazza; Andrea Ossato; Claudio Trapella; Anna Fantinati; Maria Antonietta De Luca; Giulia Margiani; Fabrizio Vincenzi; Claudia Rimondo; Fabiana Di Rosa; Adolfo Gregori; Katia Varani; Pier Andrea Borea; Giovanni Serpelloni; Matteo Marti
Journal:  Psychopharmacology (Berl)       Date:  2016-08-15       Impact factor: 4.530

6.  Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.

Authors:  Maheswari Rajasekaran; Lisa K Brents; Lirit N Franks; Jeffery H Moran; Paul L Prather
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-26       Impact factor: 4.219

7.  Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  Synapse       Date:  2012-12-08       Impact factor: 2.562

8.  Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.

Authors:  Jade M Franklin; Tamara Vasiljevik; Thomas E Prisinzano; Gonzalo A Carrasco
Journal:  Pharmacol Res       Date:  2012-11-19       Impact factor: 7.658

9.  Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.

Authors:  Tamara Vasiljevik; Lirit N Franks; Benjamin M Ford; Justin T Douglas; Paul L Prather; William E Fantegrossi; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2013-05-22       Impact factor: 7.446

10.  Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.

Authors:  Jiliang Zhang; Shaojuan Zhang; Yang Liu; Meng Su; Xiaoxi Ling; Funan Liu; Yinghui Ge; Mingfeng Bai
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-09-18       Impact factor: 3.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.